Avinger (AVGR) Posts Q1 Loss of $5.37/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Avinger (AVGR) Posts Q1 Loss of $5.37/Share

Avinger Announces First Quarter 2018 Financial Results

May 14, 2018 4:15 PM EDT

REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first quarter ended March 31, 2018.  

First Quarter and Recent Highlights

Revenue of $1.8 million for the first quarter of 2018Announced treatment of first patients globally with next generation Pantheris Lumivascular atherectomy system  Added the extended nosecone version of next generation Pantheris and announced successful first-in-patient procedures in EuropeNext generation Pantheris featured in live case transmissions at Leipzig Interventional Course... More